Progress in clinical and biological research 1990-01-01

CGP 37849 and CGP 39551: novel competitive N-methyl-D-aspartate receptor antagonists with potent oral anticonvulsant activity.

G E Fagg, H R Olpe, M Schmutz, M F Pozza, H van Riezen, H Bittiger, C Angst, D Brundish, H Allgeier, R Heckendorn

Index: Prog. Clin. Biol. Res. 361 , 421-7, (1990)

Full Text: HTML

Abstract


Related Compounds

  • CGP 39551
  • CGP 37849

Related Articles:

Competitive NMDA receptor antagonists and agonists: effects on spontaneous alternation in mice exposed to cerebral oligemia.

2004-01-01

[Pol. J. Pharmacol. 56(1) , 59-66, (2004)]

NMDA receptor antagonists acting at the glycineB site in rat models for antipsychotic-like activity.

1999-01-01

[J. Neural Transm. Gen. Sect. 106(11-12) , 1189-204, (1999)]

Effects of competitive NMDA receptor antagonists on excitatory amino acid-evoked currents in mouse spinal cord neurones.

1999-01-01

[Fundam. Clin. Pharmacol. 13(1) , 67-74, (1999)]

Effect of CGP39551 administration on the kindling of ethanol-withdrawal seizures.

2002-09-01

[Psychopharmacology 163(2) , 157-65, (2002)]

Chronic pre-explant blockade of the NMDA receptor affects survival of cerebellar granule cells explanted in vitro.

1997-03-17

[Brain Res. Dev. Brain Res. 99(1) , 112-7, (1997)]

More Articles...